Internal Medicine, Hematology & Oncology · Cincinnati, OH
NPI
1700273760
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4777 E Galbraith Rd Ste 320
Cincinnati, OH, 45236
Phone (513) 751-2273
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.7M
127,600 services
Medicare patients, 2024
379
Average age 73
Drug cost, 2024
$9.6M
2,828 prescriptions
Company payments, 2025
$8,823
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kruti Patel was code J9144 (injection, daratumumab, 10 mg and hyaluronidase-fihj), 16,020 times for 14 patients. In total Kruti Patel billed 127,600 services in 137 codes, and Medicare paid $2.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 16,020 | 14 | $39.03 | $625K |
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 15,060 | 16 | $0.29 | $4,317 |
| J0897 Injection, denosumab, 1 mg | Office | 5,400 | 11 | $20.73 | $112K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 5,150 | 39 | $37.10 | $191K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,013 | 46 | $0.09 | $265 |
| 85025 Blood Count | Office | 1,260 | 242 | $7.61 | $9,583 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,230 | 18 | $0.25 | $311 |
| 99214 Office E&M - Established | Office | 916 | 234 | $90.89 | $83K |
| 80053 Clinical Chemistry | Office | 914 | 230 | $10.34 | $9,453 |
| 82784 Immunoassay | Office | 690 | 103 | $9.11 | $6,288 |
| 96413 Chemotherapy Administration | Office | 314 | 62 | $90.86 | $29K |
| 83615 Clinical Chemistry | Office | 304 | 117 | $5.92 | $1,800 |
| 96372 Injection Administration | Office | 270 | 59 | $10.50 | $2,836 |
| 99213 Office E&M - Established | Office | 247 | 164 | $56.95 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 228 | 53 | $87.60 | $20K |
By year: 2022 $1.1M for 78,003 services; 2023 $1.8M for 102,701 services; 2024 $2.7M for 127,600 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,260 | 242 | $7.61 | $9,583 |
| 80053 Clinical Chemistry | 914 | 230 | $10.34 | $9,453 |
| 82784 Immunoassay | 690 | 103 | $9.11 | $6,288 |
| 83615 Clinical Chemistry | 304 | 117 | $5.92 | $1,800 |
| 82728 Clinical Chemistry | 94 | 47 | $13.26 | $1,247 |
| 83735 Clinical Chemistry | 94 | 43 | $6.57 | $618 |
| 83550 Clinical Chemistry | 74 | 40 | $8.57 | $634 |
| 83540 Clinical Chemistry | 74 | 40 | $6.34 | $469 |
| 84100 Clinical Chemistry | 59 | 31 | $4.65 | $274 |
| 84550 Clinical Chemistry | 35 | 20 | $4.43 | $155 |
Medicare prescription drug claims, 2024
In 2024, the drug Kruti Patel prescribed most often to Medicare patients was Acyclovir, with 254 prescriptions and refills. In total Kruti Patel wrote 2,828 Medicare prescriptions that cost $9.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 254 | 360 | 62 | $3,723 |
| Dexamethasone Generic | 150 | 161 | 31 | $1,955 |
| Valacyclovir Valacyclovir Hcl | 116 | 201 | 39 | $7,018 |
| Eliquis Apixaban | 87 | 121 | 19 | $70K |
| Gabapentin Generic | 85 | 93 | 15 | $1,076 |
| Penicillin V Potassium Generic | 80 | 149 | 21 | $1,012 |
| Revlimid Lenalidomide | 78 | 78 | 17 | $1.4M |
| Levofloxacin Generic | 76 | 86 | 52 | $596 |
| Pomalyst Pomalidomide | 75 | 75 | Under 11 | $1.7M |
| Pantoprazole Sodium Generic | 70 | 128 | 23 | $814 |
| Fluconazole Generic | 68 | 74 | 28 | $1,308 |
| Venclexta Venetoclax | 57 | 60 | 21 | $267K |
| Oxycodone Hcl Generic | 55 | 55 | 13 | $1,031 |
| Potassium Chloride Generic | 55 | 88 | 20 | $545 |
| Dapsone Generic | 49 | 77 | 20 | $2,934 |
Brand drugs: - claims; generic drugs: 2,116 claims; opioid claims: 98.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kruti Patel $8,823 ($8,823 in general payments such as food, travel and fees) from 26 companies. The largest payer was Genzyme Corporation with $6,205.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 6 | $6,205 |
| Janssen Biotech, Inc. JNJ | 5 | $1,337 |
| Abbvie Inc. ABBV | 11 | $226 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $140 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $119 |
| Pfizer Inc. PFE | 5 | $95.74 |
| Genmab U.S., Inc. GMAB | 3 | $85.83 |
| Daiichi Sankyo Inc. 4568.T | 5 | $85.24 |
| Incyte Corporation INCY | 3 | $68.44 |
| Taiho Oncology, Inc. 4578.T | 3 | $59.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.